| 000 | 01714 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250514074421.0 | ||
| 264 | 0 | _c20030828 | |
| 008 | 200308s 0 0 eng d | ||
| 022 | _a0250-7005 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHsu, H | |
| 245 | 0 | 0 |
_aCombined radiation and cytochrome CYP4B1/4-ipomeanol gene therapy using the EGR1 promoter. _h[electronic resource] |
| 260 |
_bAnticancer research _c |
||
| 300 |
_a2723-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacokinetics |
| 650 | 0 | 4 |
_aAryl Hydrocarbon Hydroxylases _xbiosynthesis |
| 650 | 0 | 4 | _aBiotransformation |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aDNA-Binding Proteins _xgenetics |
| 650 | 0 | 4 | _aEarly Growth Response Protein 1 |
| 650 | 0 | 4 |
_aGene Expression Regulation, Enzymologic _xradiation effects |
| 650 | 0 | 4 |
_aGenetic Therapy _xmethods |
| 650 | 0 | 4 |
_aGlioma _xenzymology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmediate-Early Proteins |
| 650 | 0 | 4 |
_aKidney _xdrug effects |
| 650 | 0 | 4 |
_aPromoter Regions, Genetic _xradiation effects |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 |
_aRadiation Tolerance _xphysiology |
| 650 | 0 | 4 |
_aRadiotherapy _xmethods |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aTerpenes _xpharmacokinetics |
| 650 | 0 | 4 |
_aTranscription Factors _xgenetics |
| 650 | 0 | 4 | _aTransfection |
| 650 | 0 | 4 | _aTransgenes |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aRainov, N G | |
| 700 | 1 | _aQuinones, A | |
| 700 | 1 | _aEling, D J | |
| 700 | 1 | _aSakamoto, K M | |
| 700 | 1 | _aSpear, M A | |
| 773 | 0 |
_tAnticancer research _gvol. 23 _gno. 3B _gp. 2723-8 |
|
| 999 |
_c12671050 _d12671050 |
||